Clinical Research Directory
Browse clinical research sites, groups, and studies.
Bariatric Embolization Before Sleeve Gastrectomy for Super Obese Patients
Sponsor: Centre Hospitalier Universitaire, Amiens
Summary
In patients with severe obesity, bariatric surgery provides consistent and long-term weight loss. BMI ≥50kg / m2 is an independent factor of increased morbidity / mortality in bariatric surgery compared with patients weighing less than 50 kg / m2 (1.2% and 0.8%) mainly due to technical difficulties. Preoperative weight loss reduces this morbidity / mortality. Recent studies have shown that blocking blood vessels to a particular portion of the stomach (bariatric or left gastric artery embolization) can temporarily decrease levels of the appetite inducing hormone ghrelin, and result in weight loss. The purpose of this study was to evaluate the safety and effectiveness of the association bariatric embolization before sleeve gastrectomy in super obese patients.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
0
Start Date
2023-01-10
Completion Date
2025-02-13
Last Updated
2026-06-12
Healthy Volunteers
No
Interventions
bariatric embolization
bariatric or left gastric artery embolization